These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35398800)

  • 21. Cross-sectional associations between serum PFASs and inflammatory biomarkers in a population exposed to AFFF-contaminated drinking water.
    Barton KE; Zell-Baran LM; DeWitt JC; Brindley S; McDonough CA; Higgins CP; Adgate JL; Starling AP
    Int J Hyg Environ Health; 2022 Mar; 240():113905. PubMed ID: 35065522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using large amounts of firefighting foams releases per- and polyfluoroalkyl substances (PFAS) into estuarine environments: A baseline study in Latin America.
    Pozo K; Moreira LB; Karaskova P; Přibylová P; Klánová J; de Carvalho MU; Maranho LA; de Souza Abessa DM
    Mar Pollut Bull; 2022 Sep; 182():113938. PubMed ID: 35905702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasonic degradation of per-and polyfluoroalkyl substances (PFAS), aqueous film-forming foam (AFFF) and foam fractionate (FF).
    Awoyemi OS; Luo Y; Niu J; Naidu R; Fang C
    Chemosphere; 2024 Jul; 360():142420. PubMed ID: 38795914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver and cardiometabolic markers and conditions in a cross-sectional study of three Australian communities living with environmental per- and polyfluoroalkyl substances contamination.
    Lazarevic N; Smurthwaite KS; D'Este C; Lucas RM; Armstrong B; Clements AC; Trevenar SM; Gad I; Hosking R; Law HD; Mueller J; Bräunig J; Nilsson S; Lane J; Lal A; Lidbury BA; Korda RJ; Kirk MD
    Environ Res; 2023 Jun; 226():115621. PubMed ID: 36898423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing potency factors for thyroid hormone disruption by PFASs using TTR-TRβ CALUX® bioassay and assessment of PFASs mixtures in technical products.
    Behnisch PA; Besselink H; Weber R; Willand W; Huang J; Brouwer A
    Environ Int; 2021 Dec; 157():106791. PubMed ID: 34364217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Serum Per- and Polyfluoroalkyl Substances Concentrations in Incumbent and Recruit Firefighters and Longitudinal Assessment in Recruits.
    Nematollahi AJ; Fisher JM; Furlong MA; Beamer PI; Goodrich JM; Graber JM; Calafat AM; Botelho JC; Beitel SC; Littau SR; Gulotta JJ; Wallentine DD; Burgess JL
    J Occup Environ Med; 2024 Mar; 66(3):202-211. PubMed ID: 38013397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of poly- and perfluoroalkyl substances (PFAS) in Sub-Arctic and Arctic communities in Canada.
    Garcia-Barrios J; Drysdale M; Ratelle M; Gaudreau É; LeBlanc A; Gamberg M; Laird BD
    Int J Hyg Environ Health; 2021 Jun; 235():113754. PubMed ID: 33984600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Per- and Polyfluoroalkyl Substances (PFAS) in Surface Water Near US Air Force Bases: Prioritizing Individual Chemicals and Mixtures for Toxicity Testing and Risk Assessment.
    East A; Anderson RH; Salice CJ
    Environ Toxicol Chem; 2021 Mar; 40(3):859-870. PubMed ID: 33026654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The exposure of Czech firefighters to perfluoroalkyl substances and polycyclic aromatic hydrocarbons: CELSPAC - FIREexpo case-control human biomonitoring study.
    Řiháčková K; Pindur A; Komprdová K; Pálešová N; Kohoutek J; Šenk P; Navrátilová J; Andrýsková L; Šebejová L; Hůlek R; Ismael M; Čupr P
    Sci Total Environ; 2023 Jul; 881():163298. PubMed ID: 37054786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perfluoroalkyl substances, airways infections, allergy and asthma related health outcomes - implications of gender, exposure period and study design.
    Kvalem HE; Nygaard UC; Lødrup Carlsen KC; Carlsen KH; Haug LS; Granum B
    Environ Int; 2020 Jan; 134():105259. PubMed ID: 31733527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfluoroalkyl acids including perfluorooctane sulfonate and perfluorohexane sulfonate in firefighters.
    Jin C; Sun Y; Islam A; Qian Y; Ducatman A
    J Occup Environ Med; 2011 Mar; 53(3):324-8. PubMed ID: 21346631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aqueous film forming foam and associated perfluoroalkyl substances inhibit methane production and Co-contaminant degradation in an anaerobic microbial community.
    Fitzgerald NJM; Temme HR; Simcik MF; Novak PJ
    Environ Sci Process Impacts; 2019 Nov; 21(11):1915-1925. PubMed ID: 31454014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological distress in three Australian communities living with environmental per- and polyfluoroalkyl substances contamination.
    Lazarevic N; Smurthwaite KS; Batterham PJ; Lane J; Trevenar SM; D'Este C; Clements ACA; Joshy AL; Hosking R; Gad I; Lal A; Law HD; Banwell C; Randall DA; Miller A; Housen T; Korda RJ; Kirk MD
    Sci Total Environ; 2023 May; 874():162503. PubMed ID: 36863595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Per- and Polyfluoroalkyl Substance and Cardio Metabolic Markers in Firefighters.
    Khalil N; Ducatman AM; Sinari S; Billheimer D; Hu C; Littau S; Burgess JL
    J Occup Environ Med; 2020 Dec; 62(12):1076-1081. PubMed ID: 33105404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.
    Toms LM; Thompson J; Rotander A; Hobson P; Calafat AM; Kato K; Ye X; Broomhall S; Harden F; Mueller JF
    Environ Int; 2014 Oct; 71():74-80. PubMed ID: 24980755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Per- and Polyfluoroalkyl Substances in Human Serum Samples of Selected Populations from Ghana.
    Dartey E; Ellingsen DG; Berlinger B; Thomassen Y; Odland JØ; Brox J; Nartey VK; Yeboah FA; Huber S
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perfluoroalkyl substances in a firefighting training ground (FTG), distribution and potential future release.
    Baduel C; Paxman CJ; Mueller JF
    J Hazard Mater; 2015 Oct; 296():46-53. PubMed ID: 25966923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review.
    DeLuca NM; Minucci JM; Mullikin A; Slover R; Cohen Hubal EA
    Environ Int; 2022 Apr; 162():107149. PubMed ID: 35240384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.